Genome-wide methylation analysis identifies ELOVL5 as an epigenetic biomarker for the risk of type 2 diabetes mellitus
Jooyeon Hwang(Ewha Womans University), Bong‐Jo Kim(Dongguk University), Hye‐Ja Lee(Korea National Institute of Health), Nak-Hyun Choi(Korea National Institute of Health), Jordana T. Bell(Centre for Human Genetics), Han Byul Jang(Korea National Institute of Health), Hyo‐Jung Lee(Cancer Research Institute), Jae Bum Bae(Korea National Institute of Health), Tim D. Spector(King's College London), Min Jin Go(Korea National Institute of Health), Juan Castillo‐Fernandez(Babraham Institute)
Cited by 30
Related Papers
Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study
|The Lancet Public Health|2020|2.3k
Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts
|Nature Genetics|2008|859
Host genetic variation impacts microbiome composition across human body sites
|Genome biology|2015|795